Article info

Download PDFPDF
Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis

Authors

  • Moran Hellerman Itzhaki Department of General Intensive Care, Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, IsraelSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Noam Greenberg Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelRabin Medical Center, Beilinson Hospital, Petah Tikva, Israel PubMed articlesGoogle scholar articles
  • Ili Margalit Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelInfectious Disease Unit, Rabin Medical Center, Beilnson Hospital, Petah Tikva, Israel PubMed articlesGoogle scholar articles
  • Tzippy Shochat Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelStatistical Consulting Unit, Rabin Medical Center, Beilnson Hospital, Petah Tikva, Israel PubMed articlesGoogle scholar articles
  • Ilan Krause Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelDepartment of Internal Medicine F- Recanati, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel PubMed articlesGoogle scholar articles
  • Elad Goldberg Department of General Intensive Care, Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, IsraelSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Moran Hellerman Itzhaki, Rabin Medical Center, Petah Tikva 49100, Israel; moranhe{at}clalit.org.il
View Full Text

Citation

Hellerman Itzhaki M, Greenberg N, Margalit I, et al
Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis

Publication history

  • Accepted May 25, 2021
  • First published August 5, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.